Stefan Senger
GlaxoSmithKline (United Kingdom)(GB)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Blood Coagulation and Thrombosis Mechanisms, Atrial Fibrillation Management and Outcomes, Biomedical Text Mining and Ontologies, Bioinformatics and Genomic Networks
Most-Cited Works
- → A Critical Assessment of Docking Programs and Scoring Functions(2005)1,688 cited
- → Zeolites as Transition-Metal-Free Hydrogenation Catalysts: A Theoretical Mechanistic Study(2000)120 cited
- → Discovery and structure–activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor(2010)70 cited
- → BRADSHAW: a system for automated molecular design(2019)67 cited
- → Identification of regions of the P2X7receptor that contribute to human and rat species differences in antagonist effects(2008)64 cited
- → Scientific competency questions as the basis for semantically enriched open pharmacological space development(2013)50 cited
- → Factor Xa Inhibitors: S1 Binding Interactions of a Series of N-{(3S)-1-[(1S)-1-Methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}sulfonamides(2007)49 cited
- → Structure- and property-based design of factor Xa inhibitors: Pyrrolidin-2-ones with acyclic alanyl amides as P4 motifs(2006)40 cited
- → Toward a Low-Barrier Transition-Metal-Free Catalysis of Hydrogenation Reactions: A Theoretical Mechanistic Study of HAlX4-Catalyzed Hydrogenations of Ethene (X = F, Cl, and Br)(2000)40 cited
- → The Application of the Open Pharmacological Concepts Triple Store (Open PHACTS) to Support Drug Discovery Research(2014)34 cited